-Reuters
Raymond James Maintains Outperform on MeridianLink, Raises Price Target to $35
Raymond James analyst Brian Peterson maintains MeridianLink (NYSE:MLNK) with a Outperform and raises the price target from $30 to $35.
Related Posts
Daré Bioscience Initiates Phase 1/2 Clinical Study Of DARE-HRT1
Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women's health innovation, today announced the initiation of a Phase 1/2 clinical study of DARE-HRT1.
DARE-HRT1 is a novel intravaginal ring (IVR)
BMO Capital Maintains Market Perform on NRG Energy, Lowers Price Target to $43
BMO Capital analyst James Thalacker maintains NRG Energy (NYSE:NRG) with a Market Perform and lowers the price target from $46 to $43.
Braemar Hotels & Resorts Reports Prelim. Portfolio Occupancy Of 59.2% For Aug., Average Daily Rate ~$345.88, Revenue Per Available Room $204.69
Braemar Hotels & Resorts Inc. (NYSE:BHR) ("Braemar" or the "Company") reported today preliminary portfolio occupancy of 59.2% for the month of August with an average daily rate ("ADR")